Duration of humoral response to the third dose of BNT162b2 vaccine in patients with solid cancer: Is fourth dose urgently needed?

Eur J Cancer. 2022 Nov:176:164-167. doi: 10.1016/j.ejca.2022.09.006. Epub 2022 Oct 9.
No abstract available

Publication types

  • Letter

MeSH terms

  • BNT162 Vaccine
  • Complementary Therapies*
  • Humans
  • Immunity, Humoral
  • Neoplasms*
  • Vaccines*

Substances

  • BNT162 Vaccine
  • Vaccines